Posted in | News | Business

SKion Takes Stake in SGL Carbon

The Board of Management of SGL Carbon SE was informed that SKion, the investment company of Mrs. Susanne Klatten, has acquired an equity stake of 7.92% in SGL Carbon SE. This corresponds to a total of 5,124,000 shares.

According to their notification, SKion is interested in further purchases of additional SGL Carbon SE shares, will however remain below the threshold of 25% of voting rights. SKion has built positions within this percentage scope through derivative capital market instruments.

Robert Koehler, CEO of SGL Group: “It has been our strategy for some time to obtain long term oriented shareholders due to the high volatility of equity markets. This has been achieved with Voith and LBBW. Against this background we welcome the new anchor investor SKion, which stands for value oriented and long term investments in leading technology and industrial companies.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    SGL CARBON SE. (2019, March 18). SKion Takes Stake in SGL Carbon. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=16038.

  • MLA

    SGL CARBON SE. "SKion Takes Stake in SGL Carbon". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=16038>.

  • Chicago

    SGL CARBON SE. "SKion Takes Stake in SGL Carbon". AZoM. https://www.azom.com/news.aspx?newsID=16038. (accessed November 23, 2024).

  • Harvard

    SGL CARBON SE. 2019. SKion Takes Stake in SGL Carbon. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=16038.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.